Live Breaking News & Updates on Ngitix Announces Expanded Collaboration And Licensing Agreement With Takeda To Develop New Anti Fibrotic Therapies In Inflammatory Bowel Disease

Stay updated with breaking news from Ngitix announces expanded collaboration and licensing agreement with takeda to develop new anti fibrotic therapies in inflammatory bowel disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Engitix Announces Expanded Collaboration and Licensing Agreement with Takeda to Develop New Anti-Fibrotic Therapies in Inflammatory Bowel Disease

Engitix Announces Expanded Collaboration and Licensing Agreement with Takeda to Develop New Anti-Fibrotic Therapies in Inflammatory Bowel Disease - read this article along with other careers information, tips and advice on BioSpace ....

United Kingdom , City Of , Giuseppe Mazza , Mike Platt , Exscalate Domp , Gareth Hicks , Digestive Health , University College London , Division Of Medicine , Engitix Ltd , Institute For Liver , Discovery Unit , White City Place , Netherton Investments , Ngitix Announces Expanded Collaboration And Licensing Agreement With Takeda To Develop New Anti Fibrotic Therapies In Inflammatory Bowel Disease ,